Pyridinoline (PYD) and deoxypyridinoline (DPD), two collagen-based cro
ss-links found in bone, were measured by high-performance liquid chrom
atography in urine samples from 65 control subjects and 97 patients wi
th either untreated or progressive cancer. Patients with cancer had si
gnificantly (P <0.001) higher urine concentrations of PYD and DPD than
did control subjects. Both cross-links were increased in cancer patie
nts with and without clinically detectable bone metastases, although p
atients with bone and liver involvement had higher mean concentrations
. The mean concentrations of both cross-links were also significantly
higher in the urine samples of inpatients than in an outpatient ambula
tory population. These findings suggest that the measurement of PYD an
d DPD in urine may be useful in assessing bone metastases and bone res
orption in cancer patients.